PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104620
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104620
Medical Tissue Grinder market size was valued at US$ 236.1 Million in 2025, expanding at a CAGR of 9.3% from 2026 to 2033.
A medical tissue grinder refers to any mechanical tool that is used to break down tissue samples into smaller pieces in order to get slurry that can be used in the recovery of DNA, RNA, and proteins from the sample. The structure of a medical tissue grinder includes a power drive, a detachable sample-holding unit where the sample vessel can be placed, a grinding system that can either be an agitation particle system or a conical pestle, and a cooling system to maintain the sample integrity. This enables reliable sample preparation, supporting accurate molecular analysis, diagnostics, and biomedical research applications.
Medical Tissue Grinder Market- Market Dynamics
Increasing use of personalized therapies to boost market demand
Increasing adoption of personalized therapies is driving increased use of medical tissue grinders, as sample preparation of high quality is becoming imperative in order to develop personalized diagnostic techniques and unlock biomarkers' identification and therapy development. For instance, in 2026, according to the European Commission, there will be an advance in personalized medicine as a solution to health, which is basically the integration of knowledge from various sources (genomic data, medical imaging, molecular profiling, and lifestyle information) to generate personalized therapy and prevention solutions. In addition to this, the European Commission says that by 2026, some 35% of centrally authorized medicinal products will have been developed using biotechnology processes or categorized as Advanced Therapy Medicinal Products (ATMPs), which further leads to the development of personalized medicine therapies around the world. Therefore, this is contributing to the creation and implementation of personalized medicine therapies all around the world.
The Global Medical Tissue Grinder market is segmented on the basis of Type, Application, End User, and Region.
The largest market segment by revenue is the Mechanical Type category owing to the extensive usage of these grinders in routine tissue homogenization, histopathology, molecular biology, and research laboratories. Mechanical tissue grinders will continue to dominate the market as they provide an inexpensive, reliable, and reproducible process of tissue disruption for subsequent uses like DNA, RNA, and protein isolation. As in March 2025, The U.S. National Institutes of Health (NIH) was still supporting biomedical researches with more than USD 47 billion per year in grants funding, thus driving the demand for laboratory sample preparation equipment, including mechanical tissue grinders, in academic and clinical research laboratories.
The Electric Type will be the fastest-growing market segment during the forecast period due to growing automation in laboratory testing and the need for high throughput sample preparation. In 2025, the NIH emphasized the advancements in tissue engineering automation and bioelectronics.
Medical Tissue Grinder Market- Geographical Insights
North America holds a notable position in the Medical Tissue Grinder market due to a highly developed health infrastructure, high surgical volumes, and research activities conducted. For instance, in 2026, according to the American Hospital Association (Org.), the US health infrastructure comprises a total number of 6,100 hospitals, out of which 5,121 community hospitals comprise 907,216 hospital beds. A total number of 35.7 million admissions occur through the health infrastructure. The total number of admissions is 35.7 million. There are 3,567 community hospitals in the integrated health system (Health Systems). This robust healthcare infrastructure continues to drive sustained demand for advanced medical tissue grinding solutions.
The Medical Tissue Grinder market includes companies such as Quanta System, JenaSurgical, Agency for Medical Innovations, Bertin Technologies, and Omni International, among others, trying to come up with innovations that aim at achieving precision and making medical tissue grinders more widespread in laboratories and surgeries. In March 2026, Bertin Technologies launched its partnership with the Lazuli Space Observatory project for the provision of cutting-edge optical and instrumentation solutions for what would be the largest private space telescope in the world. Such developments will enable innovation of in-house products for photonics and space technologies.
In February 2026, Quanta System established Quanta System Inc. in North Carolina. This establishment of a presence in North America is expected to promote innovation, enhance customer services, and quicken the commercialisation of our revolutionary surgical laser system.